Find uplifting stories about heroes, innovations, and solutions
152 results for "leukemia"
Researchers at University of Chicago discovered why a mutation makes adult leukemia so resistant to treatment and identified a strategy that could extend survival by a year. The breakthrough could reshape how doctors treat one in 10 adult leukemia patients.
Researchers at Memorial Sloan Kettering developed a groundbreaking CAR T cell therapy that targets leukemia while sparing healthy blood cells. The innovation came from studying patients whose cancer went into long-term remission.
Joe Slachciak, 18, is celebrating being cancer-free after spending his 17th birthday in the hospital fighting leukemia. His positive attitude and love of superheroes made him the perfect honorary survivor for Relay For Life's superhero-themed event.
Scientists discovered a protein that could help transform stubborn leukemia cells into healthy white blood cells that die naturally. The breakthrough could offer hope for patients with the most aggressive forms of blood cancer.
%252c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
Scientists at MD Anderson Cancer Center discovered an experimental therapy that stops aggressive leukemia cells even after they've become resistant to standard treatments. The breakthrough could help patients with the deadliest forms of blood cancer who have run out of options.
Researchers at the University of Oslo have found a way to halt cancer stem cells in acute myeloid leukemia by targeting a molecule previously thought to worsen the disease. The breakthrough could lead to personalized treatments that stop cancer before it spreads.
A groundbreaking blood test can predict which leukemia patients are most likely to relapse after bone marrow transplants, helping doctors personalize treatment. The discovery could transform care for thousands battling this aggressive blood cancer.
Young leukemia patients are beating cancer at remarkable rates thanks to a groundbreaking Australian treatment that swaps harsh chemo for immune therapy. Nearly 9 in 10 patients remain cancer-free three years later.
Scientists at Emory University are developing a targeted treatment for childhood leukemia that could save young lives without the harsh side effects of traditional chemotherapy. The new approach attacks cancer cells precisely, sparing hair follicles, healthy tissues, and long-term quality of life.
A breakthrough combination therapy is giving aggressive leukemia patients new hope, nearly doubling remission rates and opening the door to life-saving transplants. The treatment developed in Germany could soon become the new standard of care.
A new targeted therapy for chronic myeloid leukemia achieved major molecular responses in nearly half of patients with advanced disease. The drug, ELVN-001, performed even better in patients treated earlier, offering fresh hope in the fight against this slow-growing blood cancer.
A husband-and-wife research team turned their midnight lab conversations at the University of Virginia into ziftomenib, a newly FDA-approved drug now saving lives of leukemia patients who had run out of options. Their 17-year journey from academic research to life-saving treatment shows how university labs can tackle diseases others overlook.
When Britt Mayo was diagnosed with leukemia in 2010, one conversation about his life priorities helped him avoid chemotherapy and qualify for a trial that led to remission. Now he's helping other patients learn they have choices in their cancer care.
A 10-year-old's persistent sore throat led his mom to keep seeking answers until doctors discovered acute myeloid leukemia. Her story is helping parents learn the warning signs that could save lives.
A groundbreaking five-year research program could help two-thirds of chronic myeloid leukemia patients stop treatment forever instead of taking daily medication for life. Scientists are now focused on understanding why some patients can safely quit therapy while others cannot.
Google's new AI system just helped discover promising leukemia treatments that actually worked in laboratory experiments. This isn't science fiction anymore—it's real progress happening right now in cancer research.
Liam Sanborn, who beat leukemia four times before his 12th birthday, will lead Wisconsin's Big Climb fundraiser for blood cancer research. The warrior whose name means strength is turning his toughest moments into hope for others.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
Chinese scientists created a simple add-on that makes failing cancer treatments work again, without expensive genetic engineering. Patients who relapsed after CAR T therapy could now get a second chance at survival.
After leukemia ended her ballet career in Siberia, Masha Cherezova channeled her artistry into a new calling behind the scenes. Now she's creating a multimedia show where all proceeds support blood cancer research.
Showing 20 of 152